Exact Sciences Stock Performance
| EXAS Stock | USD 102.52 0.18 0.18% |
On a scale of 0 to 100, EXACT Sciences holds a performance score of 14. The firm owns a Beta (Systematic Risk) of -0.16, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning EXACT Sciences are expected to decrease at a much lower rate. During the bear market, EXACT Sciences is likely to outperform the market. Please check EXACT Sciences' standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether EXACT Sciences' current price history will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in EXACT Sciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, EXACT Sciences unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.16 | Five Day Return 0.18 | Year To Date Return 0.75 | Ten Year Return 1.5 K | All Time Return 583.33 |
1 | Midwest Professional Planners LTD. Acquires New Holdings in Exact Sciences Corporation EXAS | 11/17/2025 |
2 | Has Exact Sciences Rally of Over 50 percent Left Room for Further Upside | 12/04/2025 |
3 | Acquisition by Brian Baranick of 4725 shares of EXACT Sciences subject to Rule 16b-3 | 12/05/2025 |
4 | Is Exact Sciences Stock Still Attractive After a 78.1 percent Surge in 2025 | 12/19/2025 |
5 | Disposition of 14938 shares by Brian Baranick of EXACT Sciences at 101.59 subject to Rule 16b-3 | 12/24/2025 |
6 | EXAS Stock Rating Downgraded to In-Line by Evercore ISI Group - GuruFocus | 01/05/2026 |
7 | Select Medical Expands Rehab Footprint Through Vibra Healthcare JV | 01/07/2026 |
8 | BEAM Outlines Key Strategic Pipeline Goals for 2026, Stock Rises | 01/13/2026 |
9 | Exact Sciences Rose Following the Acquisition Announcement by Abbott | 01/20/2026 |
10 | Is It Time To Reassess Exact Sciences After Its Strong One Year Share Price Run | 01/23/2026 |
11 | 3 Reasons to Buy This Dividend King After Its Steep Sell-Off | 01/26/2026 |
| Begin Period Cash Flow | 609.7 M | |
| Total Cashflows From Investing Activities | -442.2 M |
EXACT Sciences Relative Risk vs. Return Landscape
If you would invest 6,963 in EXACT Sciences on November 5, 2025 and sell it today you would earn a total of 3,292 from holding EXACT Sciences or generate 47.28% return on investment over 90 days. EXACT Sciences is currently generating 0.6983% in daily expected returns and assumes 3.7628% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than EXACT, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EXACT Sciences Target Price Odds to finish over Current Price
The tendency of EXACT Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 102.52 | 90 days | 102.52 | about 25.75 |
Based on a normal probability distribution, the odds of EXACT Sciences to move above the current price in 90 days from now is about 25.75 (This EXACT Sciences probability density function shows the probability of EXACT Stock to fall within a particular range of prices over 90 days) .
EXACT Sciences Price Density |
| Price |
Predictive Modules for EXACT Sciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as EXACT Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.EXACT Sciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. EXACT Sciences is not an exception. The market had few large corrections towards the EXACT Sciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold EXACT Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of EXACT Sciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.78 | |
β | Beta against Dow Jones | -0.16 | |
σ | Overall volatility | 15.53 | |
Ir | Information ratio | 0.20 |
EXACT Sciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of EXACT Sciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for EXACT Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| EXACT Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 2.76 B. Net Loss for the year was (1.03 B) with profit before overhead, payroll, taxes, and interest of 2.14 B. | |
| EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: 3 Reasons to Buy This Dividend King After Its Steep Sell-Off |
EXACT Sciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of EXACT Stock often depends not only on the future outlook of the current and potential EXACT Sciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. EXACT Sciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 184.2 M | |
| Cash And Short Term Investments | 1 B |
EXACT Sciences Fundamentals Growth
EXACT Stock prices reflect investors' perceptions of the future prospects and financial health of EXACT Sciences, and EXACT Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EXACT Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.0109 | ||||
| Profit Margin | (0.32) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 20.95 B | ||||
| Shares Outstanding | 189.92 M | ||||
| Price To Earning | (38.17) X | ||||
| Price To Book | 7.77 X | ||||
| Price To Sales | 6.32 X | ||||
| Revenue | 2.76 B | ||||
| Gross Profit | 2.14 B | ||||
| EBITDA | (789.33 M) | ||||
| Net Income | (1.03 B) | ||||
| Cash And Equivalents | 728.04 M | ||||
| Cash Per Share | 4.11 X | ||||
| Total Debt | 2.75 B | ||||
| Debt To Equity | 0.77 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | 13.20 X | ||||
| Cash Flow From Operations | 210.54 M | ||||
| Earnings Per Share | (5.35) X | ||||
| Market Capitalization | 19.47 B | ||||
| Total Asset | 5.93 B | ||||
| Retained Earnings | (4.5 B) | ||||
| Working Capital | 839.24 M | ||||
| Current Asset | 325.86 M | ||||
| Current Liabilities | 26.72 M | ||||
About EXACT Sciences Performance
Assessing EXACT Sciences' fundamental ratios provides investors with valuable insights into EXACT Sciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the EXACT Sciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 81.12 | 121.62 | |
| Return On Tangible Assets | (0.36) | (0.38) | |
| Return On Capital Employed | (0.18) | (0.19) | |
| Return On Assets | (0.17) | (0.16) | |
| Return On Equity | (0.39) | (0.40) |
Things to note about EXACT Sciences performance evaluation
Checking the ongoing alerts about EXACT Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EXACT Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EXACT Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 2.76 B. Net Loss for the year was (1.03 B) with profit before overhead, payroll, taxes, and interest of 2.14 B. | |
| EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: 3 Reasons to Buy This Dividend King After Its Steep Sell-Off |
- Analyzing EXACT Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EXACT Sciences' stock is overvalued or undervalued compared to its peers.
- Examining EXACT Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EXACT Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of EXACT Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EXACT Sciences' stock. These opinions can provide insight into EXACT Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.